Chemoinformaics analysis of 5, 7-dihydroxyflavanone
| Molecular Weight | 568.751 | nRot | 19 |
| Heavy Atom Molecular Weight | 520.367 | nRig | 19 |
| Exact Molecular Weight | 568.34 | nRing | 3 |
| Solubility: LogS | -4.555 | nHRing | 1 |
| Solubility: LogP | 9.356 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 94.4001 |
| nHD | 2 | BPOL | 55.0979 |
| QED | 0.099 |
| Synth | 3.177 |
| Natural Product Likeliness | 0.917 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.976 |
| Pgp-sub | 0.029 |
| HIA | 0.007 |
| CACO-2 | -5.037 |
| MDCK | 0.0000149 |
| BBB | 0.02 |
| PPB | 0.997266 |
| VDSS | 0.676 |
| FU | 0.00461541 |
| CYP1A2-inh | 0.177 |
| CYP1A2-sub | 0.22 |
| CYP2c19-inh | 0.876 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.54 |
| CYP2c9-sub | 0.993 |
| CYP2d6-inh | 0.525 |
| CYP2d6-sub | 0.607 |
| CYP3a4-inh | 0.651 |
| CYP3a4-sub | 0.083 |
| CL | 5.985 |
| T12 | 0.147 |
| hERG | 0.071 |
| Ames | 0.139 |
| ROA | 0.874 |
| SkinSen | 0.959 |
| Carcinogencity | 0.053 |
| EI | 0.769 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.397 |
| Antiviral | Yes |
| Prediction | 0.683567 |